School of Medicine, Shanghai University, Shanghai, P. R. China.
Central Laboratory, Department of Neurology, Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, P. R. China.
Biotech Histochem. 2023 Nov;98(7):501-507. doi: 10.1080/10520295.2023.2240226. Epub 2023 Jul 28.
Glioma is the most common type of primary brain tumor; it exhibits great invasive capacity, morbidity and mortality. Protein kinase Cε (PKCε), a serine/threonine kinase, contributes to the development and progression of many cancers. We investigated whether knockdown of PKCε could affect the mitochondrial membrane potential of human glioma cell lines, U251 and U87, and the growth of U251 cell-derived tumors in nude mice. We found that the expression of PKCε was greater in human glioma tissues than in human normal brain tissues. Knockdown of PKCε reduced mitochondrial membrane potential in U251 and U87 cells. Knockdown of PKCε also suppressed the growth of tumors derived from U251 cells and induced apoptosis of U251 cells in vivo. Our findings indicate that PKCε is important for development and progression of glioma and may be a potential therapeutic target for glioma treatment.
神经胶质瘤是最常见的原发性脑肿瘤;它具有很强的侵袭性、发病率和死亡率。蛋白激酶 Cε(PKCε)是一种丝氨酸/苏氨酸激酶,有助于许多癌症的发展和进展。我们研究了敲低 PKCε 是否会影响人神经胶质瘤细胞系 U251 和 U87 的线粒体膜电位,以及敲低 PKCε 是否会影响裸鼠中 U251 细胞衍生肿瘤的生长。我们发现 PKCε 在人神经胶质瘤组织中的表达高于人正常脑组织。敲低 PKCε 降低了 U251 和 U87 细胞中的线粒体膜电位。敲低 PKCε 还抑制了源自 U251 细胞的肿瘤的生长,并在体内诱导 U251 细胞凋亡。我们的研究结果表明,PKCε 对神经胶质瘤的发展和进展很重要,可能是神经胶质瘤治疗的潜在治疗靶点。